Please login to the form below

Not currently logged in
Email:
Password:

bone cancer

This page shows the latest bone cancer news and features for those working in and with pharma, biotech and healthcare.

MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals

MorphoSys expands oncology pipeline with $1.7bn acquisition of Constellation Pharmaceuticals

Pelabresib, a potentially first-in-class BET inhibitor, is currently being evaluated in phase 3 clinical trials for the bone marrow cancer myelofibrosis.

Latest news

More from news
Approximately 1 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    By Jason Ward. In 2018, more than four million people across Europe were diagnosed with some form of cancer. ... These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Janssen granted Tracon Pharmaceuticals the rights to

  • Case study: Treatment guidance Case study: Treatment guidance

    Mifamurtide is a treatment for children, adolescents and young adults with a rare type of bone cancer, osteosarcoma.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Jakavi (rare bone marrow disorder); Signifor (Cushing's disease) plus 16 products in 24 pivotal trials. . ... Additional revenues for these two drugs are also promised in other cancer types not to mention their “combo” potential.

  • The distressing impact of rare diseases The distressing impact of rare diseases

    A US patient with Multiple Hereditary Exostosis (that can cause bone cancer) quoted in the report said: “Finding a doctor that can treat me is the most difficult part.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....